(Q46931144)

26 December 2017

title

Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine (English)

1 reference

26 December 2017

author name string

Jaski BE

series ordinal

1

1 reference

26 December 2017

Peters C

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

26 December 2017

American Journal of Cardiology

published in

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

63C-67C

1 reference

26 December 2017

SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

The effects of dopexamine on the cardiovascular system of the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

A sensitive radioenzymatic assay for catechol drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Some statistical methods useful in circulation research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Studies on the first derivative of the ventricular pressure pulse in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

β-Adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980070-5

10.1016/S0002-9149(88)80070-5

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017